Led by the RVC’s VetCompass Programme, researchers say the study1 was the largest exploration of cherry eye in dogs in the world.
The research team followed the anonymised veterinary health records of 905,553 dogs for a year and identified that 0.20% (1,802 dogs) were affected by this condition.
Certain breeds showed showed significantly high proportions of dogs with cherry eye, including: Neapolitan Mastiffs (4.9%), English Bulldogs (4.8%), Lhasa Apsos (1.6%) and American Cocker Spaniels (1.5%).
Importantly, say the researchers, some popular designer breeds of flat-faced dogs were also hugely affected, such as the Puggle (Pug x Beagle) (2.1%) and Jug (Jack Russell Terrier x Pug) (1.2%), suggesting the recent craze for designer crossbreeds does not eliminate health issues associated with the parental pure breeds.
Overall, brachycephalic breeds had 6.9 times the risk of cherry eye compared with dogs with medium skull length, with the Neapolitan Mastiff at the top of the league table with a risk factor of x34.
Other findings from the study included:
Dr Dan O’Neill, Associate Professor in Companion Animal Epidemiology at the RVC and lead author of the paper, said: “Given that humans designed dog breeds in the first place, we all carry a heavy responsibility to constantly improve our designs to breed away from poor health for these dogs.
"The hugely increased risks of cherry eye in popular flat-faced breeds such as English Bulldogs suggests that we have some way to go before we can consider many flat-faced breeds as designed for optimal health.
"The findings from this study will hopefully help prospective owners make better informed choices when purchasing a dog. We urge all would-be dog owners to follow advice from the UK Brachycephalic Working Group to ‘stop and think before buying a flat-faced dog’.”
Reference
'The Vet' branded surgeries were registered to Quality Pet Care Ltd which was initially acquired by CVS Group plc in August 2021.
The acquisition makes The Pet Vet not only the largest independent family-owned practice by number of sites (12) in the UK, but also the only one with a national presence.
The newly acquired surgeries are in Warrington, Portsmouth, Southampton, Bristol, Nottingham, Liverpool and Morden and Waltham Forest in London.
The Pet Vet already operates three surgeries in South Yorkshire (Barnsley, Rotherham and Doncaster) and in 2021 opened a 5,500 sq ft surgery on a retail park in Lincoln.
The Pet Vet is under the sole ownership of Rob Jones MRCVS (pictured right with Managing Director, Mel Fuller), who graduated from Bristol in 1987.
Rob practised in companion animal care in London and Australia before opening the first The Pet Vet surgery in Doncaster in 2011.
The practice now has nearly 100 employees, including 24 full time vets, and an annual turnover of over £6m.
Earlier this year, The Pet Vet secured £3.1m from alternative lender ThinCats to fund its growth plan.
A extra cash injection then allowed the family-owned independent to snap up The Vet when it came up for sale in April 2022.
Rob said: "With nearly 70% of the veterinary practice market by revenue already in the ownership of major corporations, a fact of which most consumers are still completely unaware, this is a real opportunity for us as a family business to make a positive difference for pet owners.
"Our acquisition of The Vet will allow us to further advance in-house provision, giving our vets more variety and stimulation in their working day and even greater opportunities for professional development."
The effect of changing diet on gastric ulceration in exercising horses and ponies following cessation of omeprazole treatment was conducted by Nanna Luthersson (Hestedoktoren, a private practice in Denmark) and Coby Bolger (Horse1 Spain), with colleagues from the University of Madrid and Glasgow, in collaboration with Spillers and the Waltham Equine Studies Group.
The study evaluated the effect of dietary change in combination with omeprazole treatment and after the cessation of treatment.
The 32 horses in this part of the trial had been diagnosed with significant equine squamous gastric disease (ESGD) and were in hard work.
On a random basis one of each pair was assigned to a specified low starch, fibre-based diet consisting of their own forage alongside a restricted starch, high fibre, high energy cube (Spillers HDF Power Cubes, which are commonly used in racing yards) and a high oil, low starch, chopped alfalfa based feed (Winergy Equilibrium Growth) and the other stayed on their original diet. All animals were scoped before, after the recommended course of omeprazole treatment and then six weeks after the omeprazole finished.
The horses in the no diet change group improved significantly with the omeprazole but when the treatment was stopped many regressed. Overall, by the end of the trial they were not significantly different to when they had started.
However, the horses in the dietary change group overall showed significantly improved ESGD scores, not only following the omeprazole treatment but also after the treatment had stopped. This showed that a change in diet was able to help maintain the beneficial effect of omeprazole even after the omeprazole was removed.
The study achieved an award in 2016 for research in horse welfare from the Fundación para la Promoción del Deporte Ecuestre, Spain.
Clare Barfoot RNutr, the research and development manager at Spillers, said: "This exciting work confirms what we suspected; that whilst appropriate dietary change can provide additional support to medical treatment for EGUS most importantly it can help maintain better gastric health post medical treatment."
Last year the British Equestrian Trade Association, in consultation with the Veterinary Medicines Directorate, introduced a new feed approval mark to help owners identify feeds suitable for horses and ponies prone to equine gastric ulcer syndrome (EGUS).
Currently six feeds in the UK carry the BETA Equine Gastric Ulceration Syndrome (EGUS) Certification Mark including Winergy Equilibrium Growth and Spillers Alfalfa Pro Fibre.
The new spot on, which is complementary to the Bravecto dog chew, is the only one to provide 12 week protection for both fleas and ticks, including Rhipicephalus sanguineus.
The company highlights research it carried out which showed that the convenience of Bravecto's 12 week flea and tick killing treatment improves compliance over monthly alternatives1.
The new product means practices now have more choice if they prefer to offer a spot-on or clients find compliance easier to achieve with a spot-on rather than a chew.
Amanda Melvin, Marketing Manager at MSD Animal Health said: "Our research has shown that convenience is the key to improving compliance and successfully eradicating fleas and ticks. By offering a new formulation of a 12 week treatment, Bravecto Spot-on for dogs further increases the opportunity.
"It improves the choice for vets and pet owners depending on the client’s lifestyle and type of dog.
"This new innovation also offers vets the opportunity to raise the topic of fleas and ticks with clients that have been more reluctant to use existing products.”
The applicator for Bravecto Spot-on for dogs has been designed so there is no need to remove a loose cap and no sharp edges that can scratch the pet's skin.
The launch is also supported by a range of materials for veterinary surgeons, nurses and pet owners, including information guides, a quick-fact flip book, waiting room materials, Bravecto 3+1 card and post-prescription client leaflets.
For more information, contact your MSD Account Manager.
The ten-programme series stars Cat Henstridge MRCVS, a Midlands-based locum, Cheryl Lucas MRCVS, a Vets4Pets JVP from Essex, Bristol-based James Greenwood MRCVS and Rory Cowlam MRCVS from London.
The documentary follows a wide selection of patients and conditions, from routine stuff like lump removal from a dog and dental work on a cat, through to more obscure things like an obstructed python and surgery on a goldfish.
Cat said: "I am hoping the profession will like it. It definitely features the realistic side of the job!"
To watch the show on iPlayer, visit: http://www.bbc.co.uk/cbbc/shows/the-pets-factor
The study was part of the RVC’s VetCompass programme which include anonymised veterinary information from over eight million UK dogs. From this pool, a random sample of 22,333 dogs were followed for a year, identifying all health issues that were diagnosed during this time.
The study is one of the largest ever studies to explore the anonymised health records from veterinary surgeries and report on the most common disorders in dogs. The study also looked at whether the health of dogs varied by age, sex and whether the dogs were neutered.
The main findings were:
Dr Dan O’Neill, Senior Lecturer, Companion Animal Epidemiology at the RVC and lead author of the paper, said: "This study shows that it is really important for owners to develop strong habits of caring for their dog’s teeth, ears and weight, right from the time they first acquire a puppy.
"This study shows interesting and strong correlations between human and canine healthcare: the need for good dental and bodyweight maintenance. Given how closely the lives of humans and dogs are intertwined, this should be no surprise really; we often share the same food and exercise. Owners should work closely with their vet to plan appropriate dental and weight care programmes at each visit to their veterinary clinic.”
Hannah James, Health Research Manager at the Kennel Club, and co-author of the paper, said: "As dog owners, the key priority is keeping our pets healthy and happy, but it can be difficult to put into context the most common problems that affect our canine counterparts and which areas we need to pay particular attention to in order to maintain this. These findings help us establish these key areas, and where we as owners, vets and organisational bodies can work towards to improve the day-to-day life of our beloved companions."
O'Neill, D.G., James, H., Church, D.B., Brodbelt, D.C. and Pegram, C. (2021) 'Prevalence of commonly diagnosed disorders in UK dogs under primary veterinary care: results and applications', BMC Veterinary Research.
Photo: Uwe Gelle
Bob Martin, maker of the eponymous flea treatment for cats and dogs, has announced that it will be removing the last of its permethrin-containing on-animal flea treatments from sale in supermarkets.
The company says the decision was made following a passionate outpouring of emotion - particularly online - over the large number of unnecessary deaths of cats which have been wrongly treated with permethrin-based products for dogs.
Permethrin poisoning is one of the most commonly reported poisonings in cats worldwide. According to the company, a study carried out by the Feline Advisory Bureau and the Veterinary Poisons Information Service found that 97% of permethrin poisonings in cats have followed the application of a permethrin-containing dog-specific spot on product.
Bob Martin says it believes that most permethrin poisonings are down to mistakes at point of purchase with pet owners mixing up cat and dog products, or being unaware that you cannot use a dog treatment on a cat. For this reason, the company withdrew permethrin from its dog spot ons in 2012, replacing it with fipronil.
Nevertheless, the company continued to sell cat flea collars containing permethrin, which had become indelibly associated with the deaths seen as a result of misusing the dog spot-on.
Georgina Martin, Marketing Manager and great granddaughter of founder Bob Martin said: "Animal health is Bob Martin's top priority. We have decided to reclassify our permethrin-containing on-animal flea treatments to pharmacy-only and call for a change in licensing by the Veterinary Medicines Directorate so that they may only be purchased if advice is given about their correct use.
"This is the next step in our journey as a responsible business having already voluntarily withdrawn permethrin Dog Spot-ons a few years ago which we replaced with fipronil, the same active as used in leading spot on treatments from the vet. To ensure our customers are still able to buy a flea collar from their supermarket we will be launching a new pesticide free flea repellent collar."
Nigel Grimes, Pet Food Buyer at Morrisons PLC said: "It is important for us that our customers who own animals receive the verbal advice and reassurance on the use of permethrin-containing on-animal products. We feel that this advice is needed at the point of sale and should be provided by a suitably qualified person in a pharmacy setting. We will continue to provide pet owners with on-shelf access to a choice of affordable healthcare for their animals from the Bob Martin range."
Meanwhile, Bob Martin has launched the new 'Clear' range of animal collars, which contains margosa extract from neem oil. The company says this natural ingredient is frequently used as an alternative to synthetic insecticides, and is proven to be a highly effective flea repellent, ideal for indoor cats. The new range is now on sale, with the old product being phased out as existing stocks are sold.
Centaur will continue to operate its warehouse in Castle Cary, Somerset; the new facility will allow the company to bolster its services to customers throughout Northern England, North Wales and Scotland.
AmerisourceBergen says the new Midlands facility will hold more than 13,000 products and be licensed for the wholesale distribution of veterinary and human medicines. The facility will use a state-of-the-art warehouse management software to provide efficient and accurate order fulfillment and improve the visibility of products in the supply chain.
Brian Topper, Managing Director of AmerisourceBergen Animal Health U.K. said: "Our expanded presence and capabilities in the U.K. is a reflection of the demand for high-quality solutions, and we’re growing to best meet our customers’ needs.
"Practices of all sizes rely on us to provide them with timely access to the products they need on a daily basis. With broader scope and capacity, we’ll be able to go beyond our best-in-class services and provide an unmatched customer experience by delivering critical products to practices in a more efficient and consistent manner than ever before."
The company says that the new warehouse will create more capacity at its Somerset warehouse and put the company in a positive inventory position to buffer against any business continuity challenges that may occur – ensuring that practices and their patients continue to have access to vital products.
Lisa Derbyshire, Director of Operations & Supply Chain at Centaur Services said: "As the industry moves forward, we want to ensure our customers have access to high-quality infrastructure that maximizes product safety and improves operational efficiency. Adding critical resources and upgraded service offerings, like our new distribution center in the Midlands, enables us to be at the forefront of distribution while continuing to provide the excellent service that our customers have come to know and expect from Centaur."
Elanco Animal Health has launched Vulketan, a POM-V sterile topical gel developed to encourage the healing of equine wounds.
Vulketan contains ketanserin - a serotonin-S2 antagonist.2 Elanco says that although serotonin is more widely known as a neurotransmitter in the brain, it is also found in platelets and released during platelet aggregation where it can have negative effects on wound healing.4, 7
Managing equine wounds is an everyday occurrence in equine practice1 and can be difficult and time-consuming, with many potential complications such as infection or the development of proud flesh which could delay healing or lead to reduced functionality. Repeated dressings can be a hassle for owners, and if used inappropriately can lead to their own complications.5
Elanco representative Kirsty Prudon said: "Vulketan gel is easy to use and is designed to be applied to undressed wounds, although it has been demonstrated that wounds may be dressed, if required, without affecting Vulketan's efficacy2,6.
Elanco also points to studies which it says demonstrate that Vulketan has been shown in client owned horses to be highly effective in preventing the formation of hypergranulation tissue and may facilitate the control of secondary infections.2,3,6. In addition, owners expressed satisfaction with Vulketan in over 90% of cases.6
Practising equine vet Linda Belton MRCVS said: "Vulketan is easy to use, well tolerated by horses and produces an excellent end cosmetic result and return to function. With the reduction in the need for dressings and proud flesh control Vulketan has proven to be an advantageous product which owners value."
Vulketan is suitable for use in all horses including pregnant and lactating mares. It is supplied in 75 gram tubes and should be applied twice daily.
For more information, contact your Elanco territory manager call Elanco on 01256 353131.
References
VetPartners says Valley Vets has around 200 employees, less than half of which are members of the union, although the BVU says 50% are required for recognition.
Suzanna Hudson-Cooke MRCVS, Branch Chair at BVU said: “Fees at Valley Vets have increased by 25% in two years, which is hurting pet owners whilst some staff at Valley Vets are being paid so little that they’re having to use foodbanks.
“Three years ago, VetPartners CEO Jo Malone committed to paying all staff a living wage, which still hasn’t happened”
“VetPartners did increase the salaries of lower paid members by 7.27% in the last review, but this was mostly to meet its legal obligation to pay the minimum wage.”
VetPartners responded to these points saying:
"It has been and still is our aim to pay at least the real living wage to all of our employees. We have moved closer to the aim over the past three years.
"There are 20 members of the regular team that work at Valley Vets who are below the real living wage and they are paid approximately 1.6% below that level.
"Since April 2020, we have uplifted overall salary costs at Valley Vets by 31.45% before the increase in April 2024, at a time when VetPartners, like many businesses across the UK, has been hit by a sharp rise in the cost of goods and services, interest rates and rampant inflation.
"Valley Vets’ profitability has declined over the last three years.
"We have made advances over several years in improving many benefits for our teams such as life cover, health shield, sickness and enhanced maternity cover and want to continue to do so.
"We have seen mass redundancies from other large groups and we are trying to avoid this at Valley Vets.
"The BVU in Unite requested pay and condition increases initially that would have raised employment costs by over 25% and they are currently requesting increases which would raise this by 15% which would make Valley Vets unsustainable without a significant reduction in the workforce, something we are trying to avoid.”
During annual salary reviews in 2024, we benchmarked pay for all roles within Valley Vets and they sit in the upper quartile.
"We prioritised lowest-paid team members with a 7.27% pay increase while higher paid colleagues also received an increase at a lower rate.
"We are also well aware of the affordability of care fees, and that is why we felt fees paid by our clients could not be raised any further to support significant salary increases demanded by the BVU in Unite.
The strike is due to continue till the end of July, during which time the BVU says staff are being released from the picket line as needed to provide local animals with emergency care.
Staff are not paid whilst out on strike so the BVU has started a fund, here: https://www.surveymonkey.com/r/PTVKVK3
By way of example, Emma highlights syringomyelia (SM) and mitral valve disease (MVD) in Cavalier King Charles Spaniels, two diseases which cause considerable suffering and which could be significantly reduced with selective breeding.
Following the uproar caused by the Pedigree Dogs Exposed programme in 2008, a voluntary BVA/Kennel Club SM screening programme was introduced in 2012. However, Emma says that in the time since then, during which 20,429 CKCS puppies have been registered with the Kennel Club, only 331 have been scanned.
She points out that there is still no official heart scheme in the UK, despite the Kennel Club promising at a meeting at the House of Lords in 2008 that they would introduce one.
Meanwhile, Sweden, Belgium, the Netherlands and Denmark have introduced mandatory heart testing schemes for CKCS, and the latest figures from Denmark apparently show there has been a 73% reduction in heart disease.
Back in the UK, this year's Crufts Best of Breed Cavalier sired his first litter untested when he was only 9 months old, against the recommendations of the MVD Breeding Protocol.
Emma said: "It's all very well single vets like me saying 'I'm bloody sick of this', but I don't know how we can change it unless the Kennel Club does something."
Responding in Veterinary Times, the Kennel Club’s secretary Caroline Kisko blamed the veterinary profession for the lack of progress with a heart testing scheme, saying: "The KC has been committed to developing a new heart scheme in the UK for many years but, unfortunately, the veterinary profession has been unable to agree testing protocols."
Emma said: "It is typical of the KC to blame the veterinary profession. It beggars belief to say a heart scheme is too complicated when many other countries have them already in place. At the very least the KC could insist on the well-accepted MVD breeding protocol being followed for Cavaliers. It would be a start. If we never do anything because it’s not perfect, how will we ever evolve change? Looks like us vets will just have to continue to pick up the pieces while dogs carry on dying.”
Long-time Cavalier health campaigner Margaret Carter has a petition on change.org calling for compulsory SM and MVD screening. It has amassed over 27,000 signatures. She said: "It [the Kennel Club] has been talking about a heart scheme for years. It has the know-how and power to not only create a scheme but insist breeders use it. While the Kennel Club prefers to placate its most important customers – breeders - more and more Cavalier puppies are being born to suffer from inherited disease.
"Its Assured Breeders’ Scheme (ABS) is almost meaningless for Cavaliers because the only health test required is for eyes: a token nod to health when the breed is plagued by conditions as horrific as SM and MVD.
"And with so few recorded Cavalier health tests because of the absence of a heart scheme and the breeder boycott of the official SM scheme, the KC’s Mate Select tool is rendered pretty useless too.
Margaret added: "We are very grateful to Emma Milne for voicing so powerfully the situation regarding Cavalier health, however unpalatable the truth might be to some. I’d ask all vets to follow Emma’s lead in writing to the KC and their professional bodies demanding action."
Photograph: Bailey Cooper
Suitable for both puppies and adult dogs, Eradia is presented in a bottle with an award-winning1 'All-In-One Smart Cap' which stops the person administering the product from coming into contact with the solution, is child proof and offers flexible dosing options.
Available in 30ml and 100ml bottles to cater for all dogs, Eradia can be administered either directly into the mouth or on to food.
Virbac says that Eradia has been shown to be accepted by 100% of dogs2, thereby alleviating any possible problems administering metronidazole.
For more information, contact your Virbac Territory Manager.
Mrs Mullen faced four charges against her.
The first was that she failed to provide information to her clients about her practice OOH provision.
She was also charged with discharging a Labrador, called Cleo, that was unfit to be discharged following spay surgery, with an inadequate abdominal dressing and inadequate information given to the dog's owners regarding complications from surgery, the risk of post-operative haemorrhage and arrangements for out-of-hours care, as well as failing to make adequate clinical records.
The third charge alleged that she had failed to obtain informed consent for anaesthesia/ surgery performed on an English Bulldog, called Boycie, from his owners, failed to ensure the dog had adequate monitoring whilst recovering from anaesthesia, failed to offer an adequate range of overnight care for the dog, left the dog alone overnight when it was not in a fit condition to be left, failed to provide information to its owners on post-operative care at home and out-of-hours emergency arrangements, and failed to make adequate clinical records relating to its treatment.
Finally, she was charged with failing to have Professional Indemnity Insurance (PII) or equivalent arrangements in place or failing to provide details of it, failing to respond to requests regarding her continuing professional development records and failing to respond adequately to reasonable requests from the College for details and documents regarding her treatment of the two dogs.
Mrs Mullen indicated to the RCVS before the hearing that she would not be engaging with the disciplinary process.
The Disciplinary Committee therefore granted the RCVS permission to proceed in her absence on the basis that Mrs Mullen had made it clear that her absence from proceedings was deliberate and voluntary, that there was no indication she would attend any future hearing if it was adjourned and that the charges were of sufficient seriousness that it was in the interests of animal welfare to proceed with them.
The Committee heard evidence from a number of witnesses including the animals’ owners, an expert veterinary witness and College staff.
In the evidence, the Committee heard that the Labrador had died while undergoing treatment at another veterinary practice from complications arising from blood loss following Mrs Mullen’s surgery.
The Committee also heard that the English Bulldog had suffered brain damage and had lost its sight due to post-operative hypoxia, although it had otherwise recovered.
Having heard all the evidence, the Committee found all the charges against Mrs Mullen proven.
The Committee then went on to consider whether the proven charges amounted to serious professional misconduct.
In doing so it considered the aggravating factors, including that there was actual injury to animals, that the misconduct was sustained and repeated over a period of time, that the conduct directly contravened advice issued by the RCVS, and the blatant disregard of the RCVS’s regulatory role.
It also considered that Mrs Mullen had previously been suspended from the Register by the Disciplinary Committee for two months in April 2017 for failing to have Professional Indemnity Insurance arrangements in place.
It considered that there were no mitigating factors in the case and accordingly found serious professional misconduct in relation to all the proven charges.
The Committee then considered what the most appropriate sanction would be.
Judith Way, chairing the Committee and speaking on its behalf, said: “Animal welfare lies at the heart of the veterinary profession.
"The Committee considers that [Mrs Mullen’s] treatment of Cleo and Boycie constitutes a breach of this fundamental tenet of the profession.
"Other serious findings of disgraceful conduct against [Mrs Mullen] are her failure to provide informed consent, failure to provide details about out-of-hours cover, failure to have in place Professional Indemnity Insurance (PII), continuing professional development (CPD), and failure to respond to the College’s request for information.”
The Committee considered that the conduct was so serious that the only means of protecting animal health and welfare and public confidence in the profession was to direct the Registrar to remove Mrs Mullen’s name from the Register of Veterinary Surgeons.
Judith added: “The Committee considers that [Mrs Mullen] has displayed a persistent lack of insight into the seriousness of her actions or their consequences.
"The Committee considers that [Mrs Mullen’s] conduct raises serious clinical concerns, shows disregard of obligations in relation to out-of-hours care, indicates deficiencies in making decisions, demonstrates an obstructive attitude to her regulator and creates a potential risk to patients.
"She has not engaged with the regulator, she has not demonstrated insight into her misconduct, has learned nothing from her previous suspension in relation to PII, and has done nothing to remediate her disgraceful conduct.
"There is no evidence that [Mrs Mullen} has complied with any of her obligations in relation to CPD."
“In the view of the Committee, if [Mrs Mullen] were permitted to remain on the Register, there would be a serious risk of harm to animals. She has demonstrated a reckless disregard for the obligations of a registered veterinary surgeon.”
Mrs Mullen has 28 days from being informed of the Committee’s decision to lodge an appeal with the Privy Council.
Virbac has launched Sulfatrim, the first veterinary-licensed Trimethoprim and Sulfamethoxazole (TMPS) oral antibiotic for use in rabbits, pigeons and bearded dragons.
Kate Woolley MRCVS, Product Manager, said: "Until now, no similar veterinary-licensed product has been available for these species and, in an environment where vets are increasingly aware of the responsible use of antibiotics across all species, we are very happy to launch Sulfatrim, the first licensed TMPS for rabbits, pigeons and bearded dragons."
Sulfatrim is presented in a 30ml bottle with a dispensing cap and syringe.
The range comprises four products: Calm, Seb, Pyo and Care. All four contain a new active ingredient derived from Ophiopogon japonicus called ophytrium, which Ceva says has been shown to strengthen the mechanical skin barrier1, restore the balance of protective microbial flora2 and sooth the skin1.
The new range consists of both shampoo and mousse formulations: Douxo S3 Calm is designed to sooth itchy, irritated skin while maintaining the skin barrier. Douxo S3 Pyo contains ophytrium and chlorhexidine at 3% which is both antibacterial and antifungal. Douxo S3 Seb contains ophytrium and seboliance and includes an extract from the peel of pomegranate. Ceva says it has an anti-odour action and will help with oily or flaky skin. Lastly, Douxo S3 Care (available as a shampoo only) contains ophytrium and is designed for regular use and maintenance.
The products are all free from soap, parabens, sulphates, phthalates, colourants and nanoparticles. A new, hypoallergenic ‘summertime’ fragrance has been added to the range which pet owners apparently liken to coconut and vanilla.
The Douxo S3 range comes in eye-catching packaging with a pump that can be used with one hand, an ergonomic bottle designed to be easy to grip, even with wet hands, and a visibility line so you can see the remaining quantity of the product.
Dr Melanie Rougier, corporate marketing manager at Ceva, said: “Our new range is the result of over 10 years of clients’ experience with Douxo and a robust programme of market research with four specific studies that included more than 2,000 vets and pet owners and represented over eight months of contact with pet owners. This has allowed us to gain a thorough understanding of our clients’ needs, in terms of performance, formulas, fragrance and ergonomic packaging."
Andrew Fullerton BVSc (Hons) MRCVS, product manager for Douxo at Ceva, added: "The new Douxo S3 range has been developed following extensive market research and field studies to ensure that the shampoos and mousses are not only innovative and effective, but that they are also safe and easy-to-use."
Dr Tim Nuttall BSc BVSc CertVD PhD CBiol MSB MRCVS, RCVS Specialist in Veterinary Dermatology and Senior Lecturer in Veterinary Dermatology at The Royal (Dick) School of Veterinary Studies at the University of Edinburgh, said: "I like that the performance has been proven on a basic science screening level and innovative skin model and then moving on to the in-field trials. This is what we would like to see from topical products."
Douxo S3 shampoo and mousses will automatically replace the current Douxo products via veterinary wholesalers and Ceva says it is working to convert other products in the Douxo range to S3.
For further information, contact cevauk@ceva.com, your local territory manager or visit https://www.douxo.com/uk/Pet-Skin-Care/douxo-s3.
The patient-side test identifies urinary tract infection (UTI) and the best antibiotics to treat the condition, with the results produced in minutes.
Test and Treat says the new test means that vets will no longer have to treat empirically while a urine sample is sent to an external laboratory. Nor will you have to risk delaying treatment until the results are received.
In addition, the company says that the test will help support the responsible use of antibiotics, which is particularly important given that Enterococci strains identified in canine urinary infections have been found to be resistant to three or more antimicrobials1.
U-treat is a two-part test. The first part of the test detects the presence of a urinary infection. The second part of the test looks at antibiotic susceptibility, showing the best choice of antibiotic and identifying those that won't work due to antimicrobial resistance.
Using the principles of bioluminescence, U-Treat removes host cell ATP before lysing bacterial cell walls to release bacterial ATP, which is then detected using a luminometer. The initial detection of infection test takes five minutes and the susceptibility test takes 30 minutes.
Clinical evaluation of the test in cats and dogs was carried out at University of Tennessee in conjunction with Prof. David Bemis of Cornell University. The company says U-Treat demonstrated high levels of sensitivity (97.1%) and specificity (92%), compared to lab tests.
The test is currently validated for use in dogs and cats and is being investigated for use in horses. While the test will launch first in the veterinary world, it also has scope to cross over into human medicine where there is potential to use it in general practice, paediatric and geriatric care.
Ron Turner, CEO and Scientific Director of Test and Treat said: "We've already sent our first orders to the US and have being talking at veterinary conferences about the technology - so we know vets are keen to get access to this new diagnostic test. Fast, reliable and accurate results mean that it's easier to put together a rational treatment plan that they can be very confident will work because they have the evidence."
Test and Treat is based near Newmarket in Suffolk and orders for the test are now being taken from veterinary practices in the UK. Full training will be given and the desk-top equipment (incubator, luminometer and reader) required to run the test can be supplied.
The company, which has attracted government enterprise funding, is also interested in hearing from veterinary surgeons who might be interested in investing in the technology and helping to expand its use.
To place an order, contact James Turner, General Manager on 01638 501974, email: jamest@tandtreat.com or visit http://www.tandtreat.com.
Earlier this month, veterinary surgeon Matthew Wilkinson caused a storm after giving a controversial interview to the Daily Mail to promote his book: On The Destiny Of Species. VetSurgeon member Martin Jones has read the book to find out whether the book supports the allegations. Here is his review ...
I can't deal with hypocrisy (and if I do it I want it pointed out), especially when it leads to more suffering.Matthew Watkinson, on his own fishsnorkel blog
Being subjective isn't about evidence, it's about feelings, and the most fundamental part of being subjective is the projection of extrinsic values...... i.e. X means Y to me so I will assume X means Y to X as wellOn the Destiny of Species, p.17
...it should be perfectly obvious that feelings can corrupt perspective and warp reality.On the Destiny of Species, p.18
I can only say that you make me ashamed to be human.On the Destiny of Species, p.112
On the Destiny of Species is the Book of Matthew Watkinson. It's a piece of Matthew himself: his theories, his feelings, his world view. It's the document at the centre of the storm, the cause (and topic) of much argument recently, here and on a wider stage. Matthew has attacked the veterinary profession, if not quite by going through the front door, then at least by coming in the windows. He's put his name to the accusations, has been robust in defending them and has inarguably stood by his principles. The response has not, I think, surprised him; but it may have surprised some of us. Despite not having actually read the book, many people have felt qualified to comment - often with some force.
So, in the interests of objectivity I volunteered to read the thing, and to apply some scrutiny to what the man is actually saying; we're all agreed - including Matthew - that the Daily Mail did a poor job on his behalf, reducing his argument in the minds of its readers to an attack on veterinary ethics and profits. Matthew clearly wishes to say more, so why not listen?
Before we start, I'd like to point out that I'm not here to perform a hatchet job on behalf of the veterinary profession. When I asked Matthew for a copy, I was quite open that I might hate it, and that I would say so, but that if I didn't then equally I would say so. So here goes.
Matthew kicks off by defining objectivity and subjectivity; former good, latter bad. Science and reasoning right, emotion and hypocrisy wrong. As with what is to come, he doesn't hold back on this score. However, if this was to be an objective review, in which prose, style and accessibility of content were examined, then it would be fairly short and not particularly complimentary. The typographical errors start on line two and batter the more sensitively tuned reader pretty much continuously to the end. It's rambling, poorly edited, and repetitive for much of its length (the work would decently fit into a book half its current size). It fails to engage the reader on any level that isn't centred on shared anger.
But to concentrate on the book's failing as a work of literature would be to ignore the message, and that's surely what we're here for. The theories and arguments therein are what should concern us, and I'll attempt to review them below.
First, the surprises, in particular that vets feature hardly at all. Our complicity in propagating recessive genes is tackled early on, and whether or not we feel responsible as individuals, it can't be denied that this section is one of the book's successes. The vitriol that Matthew pours into modern farming, and at the breeders behind some of our more extreme patients, is genuine and heartfelt, and he might quite validly have expanded here. Admittedly some of his conclusions are rather worrying, if only for their undeniable plausibility to the layman:
Similarly, in dogs, the congenital heart defect patent ductus arteriosus could not have become a heritable risk without veterinary surgeons
The statement shows a disturbing lack of understanding of the way that recessive genes flow through populations, with a clear implication that we fix 'em up (although I suspect almost none of us could ever attempt the feat) so that they can get back to breeding.
The book is actually about lack of objectivity in conservation, and the inconsistency in preserving a species because of its attractiveness, often at the expense of less amiable species. Matthew espouses the view that we are essentially puny humans, and that nothing we do really matters. I know now that he is Darwin's biggest fan, doesn't believe in God and is dismissive of creationists, doesn't believe that any animals reliant on conservation actually appreciate the fact, and does believe that all animals should be viewed in terms of their ability to adapt and exploit, rather than their usefulness to us:
.... conservation has nothing to do with extinct animals and everything to do with the way some people feel about extinct animals
Matthew sets himself up as the crusader and lone voice of reason, as an unequivocal judge of those who stand in the way of his theories. Among these are pretty much all conservationists, quite a number of biological and global warming scientists and anybody who indulges in post-rationalisation (those who use new evidence to retrospectively confirm their beliefs). And then he goes and says:
My decision to study veterinary medicine was based on the naïve assumption that it would involve the pragmatic application of objective selection principles
Really? At sixteen, I remember liking animals and wanting to impress girls. Those who live by the sword, Matthew. His approach to people who might seek a different view is robust, to say the least:
peace-promising Harp Seal fanatic Rebecca Aldworth.... the chief scientist of the IUCN has completely forgotten, or never actually known, that species don't evolve themselves in the right direction..... despite their own quite ludicrous beliefs...... but to anyone with half a brain...... Honestly, what the hell is wrong with these people...... is obviously controlled by idiots...... thus it should be face-punchingly obvious.....
All of which contrasts nicely with the statement made at the start of the book:
I believe that ethical diversity is as natural as biological diversity, but either way, I'm not preaching
The book makes huge promises to "conclusively destroy the empirical basis for almost everything the conservation community has ever said." It fails to do so, quite spectacularly. Matthew's interpretation of both the science and the motivation of conservation (and remember, in being objective, we should be seeking evidence) is deeply flawed and he resorts to the kind of mudslinging that ends in rubbish fights behind the bike sheds. On the more recent efforts to conserve cod stocks by harvesting other species in preference, he comes to an embarrassingly asinine conclusion:
'Atlantic Pollock...can be distinguished from cod by their greenish hue.' 119
Is that it? Are the 'stewards' really telling us to kill Pollack instead of Cod because Pollack have a 'greenish hue'?
Yes. They are.
Really, Matthew? You're actually claiming that fishermen catch Pollack because they're colour-biased, rather than because this population may currently be harvested without threat to its viability? Yes, you are. In fact, you do: it's right there on page 72.
Similarly, Matthew isn't above misappropriating the views of others to prove his point. Here, on the conservation groups which appeal to the public for funds:
Surely they don't mean the end of climate change, and rampant habitat destruction, and rapid population growth, and extreme poverty in many areas of the world, and global food shortages, and extinction threats etc. etc.
If they're promising salvation, I guess they do, and I'm sure they really believe it too. In the words of Richard Dawkins:
'...these people actually believe what they say they believe.' 376
OK, so Professor Dawkins was talking about religious fundamentalists, rather than wildly optimistic nature 'managers', but faith is faith regardless of what it's making up on the spot.
I wonder what Richard Dawkins would think about having his thoughts hijacked to somebody else's agenda? Post-rationalisation, Matthew.
Conclusions that Matthew draws from the statistics he presents are prone to error:
2 million dairy cows will suffer at least 3.1 million cases of disease every year, and if you share the incidence risk equally, each individual has a 155% chance of getting sick every year.
Perhaps I should repeat that, for all those who think life should be preserved at all costs:
If you share the incidence risk equally, each individual dairy cow has a 155% chance of getting [sic] each year.
Another stick which Matthew uses to beat the reader: the phrase 'perhaps I should repeat that'. It can be a nice conceit, a device to use sparingly when one has a show-stopping point to make; by the fourth or fifth instance, it had me clenching my teeth. The valid point here, that lameness in cattle is one of the greater scandals of modern farming (and that the RSPCA isn't entirely objective in its approach to animal welfare), is lost in the bungling of the message.
Possibly the least successful portion of the book is where Matthew attempts to take on climate change and the science behind it. Now, I'm not sure that either Matthew or I are equipped to take this on, and there is a fair amount of confusion evident as a result, not to mention some self-contradiction about the importance of the role of carbon dioxide. He also clings to the quaint notion that because the earth hasn't died yet, it won't. It brings to mind the apocryphal story of the Bronx housewife, on being arrested for murdering her husband, "Whaddya mean - I stabbed him loadsa times before and he never died". It's pretty likely that when the human race kills itself off, plenty of other lifeforms will flourish - but the simple facts are that we don't know how and when we're going to do it, or how much we'll destroy on the way out. I was particularly tickled by Matthew's assertion that dumping nuclear waste into the rainforests is
.....a good plan that will inevitably fall on deaf ears
In asserting that all lives must end, but Life will continue indefinitely (neatly ignoring the principle that entropy will eventually win, but not for a little while yet), Matthew aims to apply objective scrutiny to the abiding principles of conservation - and thereby expose it for the pointless sham that he believes it to be. However, such an approach to our relationship with our ecosystem and to individuals' rights to life may help to reduce sentimentality, but it's also distinctly joyless and seeks to take from humans their capacity to find pleasure in activities that don't necessarily influence their own survival. Like it or not, we've evolved to enjoy stuff, we're the dominant species and Darwinism dictates that we strive to maintain this status. If we want to save a bunch of polar bears, we can. It might help, it might not. If we want to cull jellyfish so that our marine food stocks are safeguarded, then we're following simple Darwinian principles. But as the species that made it through to master abstract thought, to at least understand the principle of altruism and to be able to seamlessly construct shields against our own hypocrisy, we can save what we like, when we like. Matthew seems to be angry about this, and that's not entirely healthy.
There are points to be made here: Matthew wants to take on the indiscriminate dog breeders; he rightly pulls up some of the eco-babble that promises total world destruction - and the unwarranted guilt that it engenders; he makes a nice point about the parallels between ecological proselytising and religion - but then ruins it by repeating it over and over again, page after page. Simply, if rather brutally, the book doesn't work for me on any level. I wasn't convinced by a single argument that I hadn't already considered and I found it an absolute chore to read.
I apologise to Matthew. I wanted to be positive and to be able to demonstrate that his actions were at least well-motivated, and had allowed him to bring something to the table with his book. But I fear that he'll be remembered simply as the man who tried to fight overcharging in the profession, and it's clear that that's the one point he hasn't actually tried to make.
One last thing. Matthew contends that we must strive for objectivity, and that we should fight hypocrisy. He makes the clear point that dead animals do not have feelings, and that to give them significance is subjective. In his words elsewhere though, he has described how in dealing with his agent, he became frustrated by the lack of pace; Darwin's great work was nearing its 150th anniversary, and in order to tie in properly with this it was imperative that the book be published without delay.
To this, I have to say: the anniversary wasn't aware of the book's arrival. The anniversary has no thoughts on the matter; it isn't animate or sentient or in any way aware. The anniversary didn't care whether or not it was celebrated. In fact, the:
.... [celebration of the anniversary] has nothing to do with [the anniversary itself] and everything to do with the way some people feel about [anniversaries]
The subjective course of action was to sack the agent and self-publish in a hurry. The objective course of action would have been to retain the agent, forget about an arbitrary date and get a good editor in. There was the basis of a decent book here: Matthew has some things to say; unfortunately, he seems to have gone out of his way to make sure that few people want to listen, both in the writing of the book and in its promotion. What a shame.
To Matthew, I apologise again. I wish you the best of luck, I respect and defend your right to air your beliefs and if I'd liked the book, I would have said so. To others, who might accuse me of kicking a man when he's down, I say that I cannot hurt the man financially: Matthew has now started to give the book away as a pdf download. You can find it, along with debate and biography, on his blog:
http://fishsnorkel.wordpress.com/
The overview starts with the CMA noting how it has had significant dealings with many vets and nurses from different practices and acknowledging their dedication and commitment to owners and their animals.
Nevertheless, the CMA has identified various areas of concern about the state of the marketplace:
The CMA says it will publish three further papers in the spring, one sharing its analysis of treatment and pricing data from two large insurance companies, another in which it will lay out its proposed remedies to the concerns it has raised, and a final one analysing the profitability of veterinary businesses.
https://www.gov.uk/cma-cases/veterinary-services-market-for-pets-review#working-papers
The Veterinary Record has published new research which shows that one in seven vets is likely to be burnt-out within 10 years of qualifying.
The study was conducted by a team of Dutch researchers led by Nicole Mastenbroek (pictured right) from the Faculty of Veterinary Medicine at Utrecht University.
They noted that veterinary surgeons' psychological wellbeing has been the subject of several studies in different countries in recent years, with some evidence suggesting that male vets are less prone to distress, anxiety, and depression. They wanted to gauge the level of burn-out and engagement with work among vets that had graduated within the past decade, and to assess whether gender or years since graduation are influential factors.
The researchers say they based their approach on the job demands-resources (JD-R) questionnaire, which balances out negative (burn-out) and positive (engagement) aspects of wellbeing associated with work. However, they tailored it specifically for veterinary surgeons, on the grounds that every profession has unique risk factors for burn-out.
The questionnaire was emailed to 1,790 vets who had qualified in The Netherlands between 1999 and 2009, with the final analysis based on the responses of 860, almost three quarters (73%) of whom were women.
Levels of exhaustion and cynicism - both of which are associated with burn-out - were significantly lower than those in a random sample of the Dutch working population. But so too was the level of work engagement.
The responses showed that one in seven respondents (14%) was burnt-out within 10 years of qualifying.
The researchers say that if the criteria for burn-out that are normally used for the Dutch workforce are applied, then the responses would indicate that 27% of the survey respondents were burnt-out.
Women also seemed to reach burn-out faster. Almost one in five (18%) of the female respondents was burnt-out within five years of graduating.
Male vets tended to be less exhausted and more engaged with work than their female peers. Job demands associated with exhaustion were work/home life balance and workload, while job resources linked to engagement included opportunities for professional development and "skills discretion" - the ability to use and develop skills on the job.
Researchers says that behavioural traits explained more of the variance in levels of work engagement between male and female vets than in levels of exhaustion.
Self-belief in one's abilities (self-efficacy) and a proactive stance are linked to work engagement in the JD-R approach. But women vets rated themselves as less effective, optimistic, proactive and assertive than did their male peers.
British Veterinary Association President Robin Hargreaves said: "These findings are worrying but sadly not surprising. We know that a burn out and other manifestations of poor mental wellbeing in veterinary professionals of both sexes are a well-recognised problem in the UK and they are a constant concern to BVA.
"The suggestion of an increased susceptibility to burn out amongst female vets adds to that concern with the increasing proportion of women in the profession."
Equine glandular gastric disease is a complex syndrome that is distinct from gastric ulceration. A number of studies now indicate that it is an inflammatory gastritis, predominantly at the gastric outflow, which has different causes and risk factors from gastric ulcers. As such, medication effective in treating gastric ulceration may be less effective for this specific condition.
The clinical signs of EGGD are diverse and non-specific and may be mild or recurrent. They may include changes in temperament, changes in rideability, unexplained weight loss, reduced appetite or cutaneous sensitivity manifesting as biting of the flanks or resentment of girthing, grooming, leg aids or rugging. Recommendations for reducing the prevalence of disease, based on putative risk factors, include providing rest days from work, maximising turn-out, minimising management changes and other potential stress factors and minimising changes in equine companions and human carers.
The new guidelines have been published by a group of equine medicine specialists, based on a review of published and unpublished evidence. The intention is to provide veterinary practitioners with up-to-date guidance on risk factors, diagnosis, treatment, dietary management and prevention of EGGD.
David Rendle, an internal medicine specialist at Rainbow Equine Hospital in North Yorkshire who chaired the group and is a consultant editor of UK Vet: Equine said: "Our findings challenge long-standing dogma on EGGD, a condition about which there is currently very little advice available to vets and horse owners. It is becoming increasingly clear that the distinction between disease of the squamous and glandular mucosa is important clinically and the group felt that updated guidance may help to improve management of EGGD in practice."
Provision of evidence based clinical guidelines should enable practitioners to adopt more standardised and logical approaches and base EGGD management decisions on the most current data.
Professor Josh Slater, Professor of Equine Clinical Studies at the Royal Veterinary College said: "Clinical guidelines are commonly used in human health care and have been shown to improve clinical outcomes by condensing data from large numbers of research publications and promoting rapid adoption into clinical practice. These new guidelines represent a step forward in the management of this complex condition by combining a consensus of expert opinion with the best available current clinical research and evidence."
Mark Bowen, Professor of veterinary internal medicine at the University of Nottingham who is based at Oakham Veterinary Hospital said: "Whilst the panel hasn’t come up with miracle cures there was universal agreement that new treatment options have to be integrated in a logical and responsible manner."
"Our understanding of this condition is in its infancy but we hope that the summary document, which also highlights the gaps in our knowledge, will provide a useful framework for vets to follow and will be a stimulus for future research."
The guidelines can be found here: https://www.magonlinelibrary.com/doi/full/10.12968/ukve.2018.2.S1.3
Photo: Marked multi-focal depressed haemorrhagic and fibrinosuppurative lesions
The OIE represents 178 Member countries and territories with international surveillance programmes that monitor antigenic drift among equine influenza viruses, and its Expert Surveillance Panel (ESP) for EIV makes annual recommendations for the composition of equine vaccines.
ProteqFlu, manufactured by Merial Animal Health, is currently the only vaccine in Europe to meet these recommendations.
Brand manager Dr Clare Turnbull said: "These recommendations, which have been in place since 2011, call for the inclusion of both Florida Clade 1 and 2 strains; as these are representative of the EIV strains that competing horses encounter globally.
"Although all licensed vaccinations should give clinical protection to individuals when challenged with a heterologous strain, mathematical modelling demonstrates that when scaled up to population level, this mis-match between challenge strain and vaccine strain significantly increases the risk of an epidemic occurring."
The FEI imposes mandatory equine influenza vaccination for horses competing under their jurisdiction to improve equine welfare by reducing clinical disease in individuals; but also because of the financial losses that an outbreak could have on the equine sport industry.
Göran Akerstrom, veterinary director of the FEI said: "The FEI has been a part of a Public Private Partnership with OIE for many years and we admire the work that they do in disease surveillance and global animal health.
"We stand behind their recommendations on vaccination for equine influenza and recommend our athletes to discuss these with their veterinary surgeons when considering their vaccination schedules."
For further information on FEI vaccination requirements visit https://inside.fei.org/node/3289
Harrison Family Vets opened its first practice earlier this month in Woodley, Reading, in a £350,000 investment that created eight jobs.
The plan is for the next practice to open later this summer in the Midlands, before the group expands north towards the end of the year. The group is now searching for further properties across the north and south of England, with plans to open 75 practices by the end of the decade.
Tim joined his dad's practice in 1995 as General Manager. He later co-founded Vets4Pets in 2001 before joining Mars Inc. to head the overseas growth of Banfield, then the world’s largest veterinary practice. He then rejoined the family business to grow it further, until it was acquired by IVC Evidensia in 2018.
Alongside Tim is operations director, Kristie Faulkner who also worked at White Cross Vets until it was acquired by IVC, whereupon she became regional operations manager, overseeing more than 200 of the IVC's practices across the South East of England.
Between 2012 and 2018, White Cross Vets was repeatedly named as one of the UK’s best employers and a truly extraordinary place to work. The company secured a place in the prestigious ‘Top 100 Sunday Times Best Small Companies to Work For’ league table for seven consecutive years, as well as being the inaugural SPVS Wellbeing Award Winners.
Tim said: “The whole ethos at Harrison Family Vets is about fostering a culture within our team that sets us apart and differentiates our practice from all others. Every individual’s strengths and personality traits will contribute to what we do, in a family-orientated environment. Our culture is about looking after people. Focus on attracting the very best people and then look after them as much as possible. A successful practice with a fabulous reputation amongst the profession and amongst clients is what automatically follows.
“Our state-of-the-art clinics boast extensive facilities including on-site laboratories, full x-ray suites, operating theatres, ultrasonography and separate dog and cat wards that have been carefully designed with mood lighting, aromas and music to offer a calming atmosphere.
We’ve also worked hard to create a customer experience that’s more akin to an Apple store, than a traditional veterinary practice. We don’t have a reception desk and instead, our front of house team have the autonomy to freely interact with our clients and their pets.
Our waiting areas feature bespoke pods, which give clients their own space and offer pets privacy, thus shielding them from the stresses of facing other pets in a traditional waiting room. Each pod also has its own tablet where clients can update their details, sign up to our Total Wellness Plan or even order fresh and healthy dog food from Butternut Box.
“Everyone wants to know why we want to start another veterinary group now. For Kristie and I the timing is perfect as there is a clear void to fill. The people-focused independent practice is becoming a thing of the past and is what the profession is yearning for. This will attract the very best team members which in turn will provide a superior client and pet experience.
"Creating a successful business and building a fantastic team is incredibly exciting and we genuinely believe Harrison Family Vets can become the most innovative, forward-looking and caring practice, as well as the employer of choice for vets and nurses, in the UK.”
VetSurgeon.org wishes Tim and Kristie all the very best luck in the world with their new venture, although one suspects that they won't need to rely on luck. White Cross under his direction was consistently doing extraordinary things to foster what seemed to be a remarkably good working environment. If they can come close to repeating the formula, or improving on it, they must be on to a winner.
Equip EHV 1,4 is licensed for the active immunisation of horses to reduce clinical signs due to infection with Equine Herpesvirus 1 and 4 and to reduce abortion caused by EHV-1 infection.
Zoetis says it has already communicated directly with veterinary surgeons to inform them that Equip Rotavirus will be out of stock from the end of November 2017 until mid-2018.
During this time an imported vaccine for Rotavirus, will be available to provide an interim solution until supply is restored.
Practices wanting to buy the alternative imported Rotavirus vaccine will need to apply to the VMD for a Special Treatment Certificate (STC).
The company says it acknowledges the concern and frustration this causes its customers and wants to reassure the equine community that it is working diligently to restore the supply of Equip Rotavirus as soon as possible.
For more information, contact your Zoetis account manager or Zoetis technical team.
Animalcare has launched Buprecare into the UK and Ireland veterinary markets. Buprecare (POM-V) is a veterinary licensed analgesic, containing buprenorphine, for use in dogs and cats. It is licensed for post-operative analgesia in dogs and cats, and potentiation of the sedative effect of centrally acting agents in dogs.
This is the second major product the company has introduced in the last 18 months as Animalcare continues to grow its portfolio of veterinary products with the launch of an ACE inhibitor Benazecare (benazepril hydrochloride) earlier in 2007.
To complement the product launch, Animalcare is offering an ampoule breaker to help practice staff to open ampoules safely, together with a practice support package, containing pain scoring pads to aid in the assessment of pain of patients and judging of adequate analgesia requirements. In addition a dosing table and poster detailing common behavioural changes that can be associated with pain are available. Buprecare 0.3mg/ml is available in 1ml ampoules, in cartons of 5 ampoules.
Stephen Wildridge, Managing Director of Animalcare Ltd. said: "We have a very exciting time ahead with the launches of several new pharmaceutical products over the next twelve months, and the proposed expansion of our business into the major European veterinary markets."
Please contact your Animalcare representative, or ring 01904 487687 for more details.